| MYELOMA MINUTE | Up To The Minute News | 12.3.2020 |
|
 |
 |
| Staying Positive and Strong in Times of Crisis: A Prescription for Resilience |
| We got some good news this week that COVID-19 vaccines are on the horizon. But even when they are widely available, we will need to stay vigilant. IMF Chairman Dr. Brian G.M. Durie says to think of the approach as the “Swiss cheese model.” Each layer of protection has a few holes, but when stacked together, the layers become stronger. |
|
|
 |
| Register NOW for the 2020 American Society of Hematology’s Virtual Symposium |
| In partnership with Clinical Care Options LLC, the International Myeloma Foundation presents the webinar “Accelerating Toward Curing Myeloma: New Data, New Agents, and Evolving Treatment Paradigm,” on Friday, December 4 at 11 a.m. PT / 1 p.m. CT / 2 p.m. ET. The expert panel includes IMF Chairman of the Board Dr. Brian G.M. Durie (Cedars-Sinai — Los Angeles), Dr. Thomas G. Martin (University of San Francisco — San Francisco), Dr. Philippe Moreau (University Hospital — Nantes, France), Dr. S. Vincent Rajkumar (Mayo Clinic — Rochester, Minnesota), and Dr. Jesús San Miguel (Universidad de Navarra — Pamplona, Spain). For healthcare professionals, a CME/CE-activity is available upon completion of the webinar. |
|
|
 |
| Register Now for FREE for the Popular Livestream: the IMWG from ASH |
| Tune in to the IMWG Conference Series at 8 a.m. PT / 11 a.m. ET on Tuesday, December 8. The IMF’s International Myeloma Working Group, a collaborative body of some of the world’s top myeloma experts, will convene at this year’s virtual 62nd American Society of Hematology (ASH) annual conference. The following doctors from the IMWG will share the latest news and trends of the treatment of myeloma: IMF Chairman of the Board Dr. Brian G.M. Durie (Cedars-Sinai Outpatient Cancer Center — Los Angeles), IMF Chief Medical Officer Dr. Joseph Mikhael (TGen, City of Hope — Scottsdale, AZ), Dr. María V. Mateos ( University of Salamanca — Salamanca, Spain), and Dr. Thomas Martin (University of California at San Francisco — San Francisco). Don’t miss this patient- and caregiver-friendly event! |
|
|
 |
| Hot off the Press: the Fall 2020 Edition of Myeloma Today |
| The latest edition of Myeloma Today now available as a free download or printed copy marks the IMF’s 30th Anniversary! Read about the highly successful 11th Annual Summit of International Myeloma Working Group, as well as an update on the CANDOR clinical trial, and more. Medical articles are translated and available in French, Italian, German, and Spanish. |
|
|
 |
| IMF Support Group Leaders Have Their Fingers on the Pulse of ASH 2020 |
| Tune in as the IMF’s myeloma support group leaders and patients participate in the virtual 62nd annual meeting of the American Society of Hematology (ASH), an exciting convergence of 20,000 healthcare professionals from around the world. Start following the IMF ASH team members now on social media as they share the latest clinical updates in myeloma research, therapies, and practice strategies via Twitter (#ASH20 and #IMFASH20), Facebook, blogs, and videos. Visit the link below for all the latest updates! |
|
|
 |
| We Could Not Continue to Thrive Without You! |
| This year, the IMF is grateful for all you have done to help keep our programs thriving. As part of GivingTuesday, you raised nearly $40,000 for our organization. When you donate to the IMF, your contribution goes to funding crucial programs that impact the lives of myeloma patients, caregivers, and healthcare professionals around the world. We are so grateful for your support! |
|
|
 |
| And This Too Shall Pass… |
| Once again, the IMF is hosting a raffle for a 10-day stay at the Villa Ono Oasis in historic Kailua-Kona, Hawaii. While many of us have been affected by COVID-19, we hope to remind you that this too shall pass. If you purchase the winning $50 raffle ticket, you could find yourself just minutes from the Hawaiian coastline. The winner will be announced on April 2, 2021. Note: Bookings will be in the future based on mutual availability with you and the property owner. |
|
|
 |
| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series |
This Week’s Question:
What does the approval of Darzalex Faspro™ mean for myeloma patients? |
|
|
| |
|
|
| |
We Thank Our Sponsors:
|
| Amgen; Bristol-Myers Squibb; Genentech; GSK; Oncopeptides, Inc.; Sanofi-Genzyme; and Takeda Oncology |
| We also thank individuals like you for your continued support! |
|
|
| Join the conversation at The International Myeloma Foundation |
 Facebook: /Myeloma |  Twitter @IMFMyeloma |  Instagram @IMFmyeloma
www.myeloma.org |
This email was sent by:
The International Myeloma Foundation
12650 Riverside Drive, Suite 206
North Hollywood, CA 91607-3421
Connect with the IMF InfoLine
1-800-452-2873 |
We respect your privacy and your preferences for communications of this nature.
Home • Unsubscribe • Privacy Policy |
| View as web page |
